Nūmi

Nūmi is a French biotech company developing a cellular agriculture bioproduction platform based on human mammary cells. The company cultivates these cells in vitro to recreate breast milk and produce key bioactive ingredients for nutrition across all stages of life, with a focus on cases where breastfeeding is not an option. It describes itself as the first European cultivated breast milk company.

The platform is designed to produce the 1,500-plus bioactive molecules found in breast milk. Targeted compounds include lactoferrin, human milk oligosaccharides (HMOs), antibodies and essential fatty acids such as DHA and ARA, which support immunity, brain development and infant health. The resulting ingredients are positioned for infant nutrition and broader life-stage nutrition applications.

Nūmi is an early-stage, VC-backed company headquartered at Hôpital Cochin in Paris, working with scientific partners and investors. Its stated areas of technical work span cellular agriculture, cultivated nutrition, bioproduction and human mammary cell cultivation, spanning the biotech, infant nutrition and cultivated foods sectors.